WASHINGTON — Another giant is bringing it home. On Tuesday, October 6, 2026, BD (Becton, Dickinson and Company), the nation’s largest maker of essential medical consumables, announced a landmark partnership with the Trump administration to expand American manufacturing and secure the supplies that hospitals and patients count on every day.
President Donald J. Trump broke the news on Truth Social late Monday: “HUGE INVESTMENT WIN for NEBRASKA AND THE U.S.! Beckton Dickenson (BD), one of the largest Medical Device Manufacturers, has agreed to an Investment of 3 BILLION DOLLARS to Onshore Manufacturing of Essential Medical Products (syringes, needles, lab kits, and more) that American Patients and Hospitals depend on.” He added that the biggest expansion will be in Nebraska, more than $1 billion, and gave the reason: “my strong Medical Device TARIFFS, which will be in place by the end of the year.”
BD’s own announcement goes even bigger. The company intends to invest $19 billion in the United States over several years, including capital, operations, and supply chain, with $3 billion aimed at expanding U.S. manufacturing. It will make about 5 billion more essential medical consumables in America every year, raising its share of domestically supplied products to roughly 80%, and it will manufacture 100% of the BD needles used in America here at home with American-made steel. As the President put it: “No one likes needles — But, if you need one, it should be made of American Steel in the U.S.A.”
“The administration recognizes the importance of investing in a stronger, more secure healthcare supply chain,” said BD Chairman and CEO Tom Polen, “and BD is uniquely positioned to help bring that vision to life.” The deal also gives BD relief from future Section 232 tariffs on covered products as long as it hits its agreed milestones. That is the Trump formula: build here and you win, and America wins too. BD’s U.S. plants include Columbus and Broken Bow, Nebraska; Canaan, Connecticut; Añasco, Puerto Rico; Sandy, Utah; El Paso, Texas; Covington, Georgia; and Sumter, South Carolina.
It follows Bayer’s $2.2 billion Ohio pharmaceutical campus and a wave of companies racing to build in America. Watch the Official White House video: President Trump is bringing back MADE IN AMERICA.
